These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17077962)

  • 1. Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions.
    Trog D; Moenkemann H; Breipohl W; Schueller H; Schild H; Golubnitschaja O
    Amino Acids; 2007; 32(3):373-9. PubMed ID: 17077962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells.
    Trog D; Yeghiazaryan K; Fountoulakis M; Friedlein A; Moenkemann H; Haertel N; Schueller H; Breipohl W; Schild H; Leppert D; Golubnitschaja O
    Eur J Pharmacol; 2006 Aug; 542(1-3):8-15. PubMed ID: 16806166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
    Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
    Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment.
    Trog D; Moenkemann H; Haertel N; Schüller H; Golubnitschaja O
    Amino Acids; 2005 Mar; 28(2):213-9. PubMed ID: 15723240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted resistance of gliomas to temozolomide.
    Bocangel DB; Finkelstein S; Schold SC; Bhakat KK; Mitra S; Kokkinakis DM
    Clin Cancer Res; 2002 Aug; 8(8):2725-34. PubMed ID: 12171906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
    Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
    J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
    Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
    J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
    Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
    Hirose Y; Berger MS; Pieper RO
    Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells.
    Inaba N; Kimura M; Fujioka K; Ikeda K; Somura H; Akiyoshi K; Inoue Y; Nomura M; Saito Y; Saito H; Manome Y
    Anticancer Res; 2011 May; 31(5):1653-8. PubMed ID: 21617223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
    Gramatzki D; Herrmann C; Happold C; Becker KA; Gulbins E; Weller M; Tabatabai G
    PLoS One; 2013; 8(5):e63527. PubMed ID: 23667632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU.
    Gomez-Manzano C; Lemoine MG; Hu M; He J; Mitlianga P; Liu TJ; Yung AW; Fueyo J; Groves MD
    Int J Oncol; 2001 Aug; 19(2):359-65. PubMed ID: 11445852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions.
    Trog D; Fountoulakis M; Friedlein A; Golubnitschaja O
    Proteomics; 2006 May; 6(9):2924-30. PubMed ID: 16596702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.
    Alexiou GA; Gerogianni P; Vartholomatos E; Kyritsis AP
    Cancer Invest; 2016 Nov; 34(10):489-495. PubMed ID: 27768402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M; Rabkin S; Martuza RL
    J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines.
    Combs SE; Bohl J; Elsasser T; Weber KJ; Schulz-Ertner D; Debus J; Weyrather WK
    Int J Radiat Biol; 2009 Feb; 85(2):126-37. PubMed ID: 19280465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.
    Rocha CR; Garcia CC; Vieira DB; Quinet A; de Andrade-Lima LC; Munford V; Belizário JE; Menck CF
    Cell Death Dis; 2014 Oct; 5(10):e1505. PubMed ID: 25356874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.
    Han S; Li Z; Master LM; Master ZW; Wu A
    Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.